SEC Form 4 · accession 0001078782-17-001707
Zivo Bioscience, Inc. · ZIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher D. Maggiore
Director · 10% Owner
Period of report
Dec 14, 2017
Accepted (ET)
Dec 20, 2017 · 11:45 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001101026
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 14, 2017 | P | 8,000 | $0.10 | A | 14,020,831 | D | |
| Common Stock | Dec 15, 2017 | P | 10,000 | $0.10 | A | 14,030,831 | D | |
| Common Stock | Dec 18, 2017 | P | 6,000 | $0.09 | A | 14,036,831 | D | |
| Common Stock | Dec 19, 2017 | P | 101,000 | $0.09 | A | 14,137,831 | D |
Table II — derivative securities
No Table II lines on this filing.